Decentralised clinical trials in multiple sclerosis research
Randomised controlled trials (RCTs) play an important role in multiple sclerosis (MS) research, ensuring that new interventions are safe and efficacious before their introduction into clinical practice. Trials have been evolving to improve the robustness of their designs and the efficiency of their...
Saved in:
Published in | Multiple Sclerosis Journal Vol. 29; no. 3; pp. 317 - 325 |
---|---|
Main Authors | , , , , , , , , , , |
Format | Book Review Journal Article |
Language | English |
Published |
London, England
SAGE Publications
01.03.2023
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Randomised controlled trials (RCTs) play an important role in multiple sclerosis (MS) research, ensuring that new interventions are safe and efficacious before their introduction into clinical practice. Trials have been evolving to improve the robustness of their designs and the efficiency of their conduct. Advances in digital and mobile technologies in recent years have facilitated this process and the first RCTs with decentralised elements became possible. Decentralised clinical trials (DCTs) are conducted remotely, enabling participation of a more heterogeneous population who can participate in research activities from different locations and at their convenience. DCTs also rely on digital and mobile technologies which allows for more flexible and frequent assessments. While hospitals quickly adapted to e-health and telehealth assessments during the COVID-19 pandemic, the conduct of conventional RCTs was profoundly disrupted. In this paper, we review the existing evidence and gaps in knowledge in the design and conduct of DCTs in MS. |
---|---|
AbstractList | Randomised controlled trials (RCTs) play an important role in multiple sclerosis (MS) research, ensuring that new interventions are safe and efficacious before their introduction into clinical practice. Trials have been evolving to improve the robustness of their designs and the efficiency of their conduct. Advances in digital and mobile technologies in recent years have facilitated this process and the first RCTs with decentralised elements became possible. Decentralised clinical trials (DCTs) are conducted remotely, enabling participation of a more heterogeneous population who can participate in research activities from different locations and at their convenience. DCTs also rely on digital and mobile technologies which allows for more flexible and frequent assessments. While hospitals quickly adapted to e-health and telehealth assessments during the COVID-19 pandemic, the conduct of conventional RCTs was profoundly disrupted. In this paper, we review the existing evidence and gaps in knowledge in the design and conduct of DCTs in MS. |
Author | Garjani, Afagh Tallantyre, Emma C das Nair, Roshan Evangelou, Nikos Planchon, Sarah Marie Gerry, Stephen William Gunzler, Douglas David Liu, Brandon Jun-Yu Allen, Christopher Martin Chataway, Jeremy Ontaneda, Daniel |
Author_xml | – sequence: 1 givenname: Afagh orcidid: 0000-0001-9271-346X surname: Garjani fullname: Garjani, Afagh organization: Mental Health and Clinical Neurosciences Academic Unit, School of Medicine, University of Nottingham, Nottingham, UK/Academic Neurology, Nottingham University Hospitals NHS Trust, Nottingham, UK – sequence: 2 givenname: Brandon Jun-Yu surname: Liu fullname: Liu, Brandon Jun-Yu organization: School of Psychology, University of Nottingham, Nottingham, UK – sequence: 3 givenname: Christopher Martin orcidid: 0000-0002-8225-8747 surname: Allen fullname: Allen, Christopher Martin organization: Mental Health and Clinical Neurosciences Academic Unit, School of Medicine, University of Nottingham, Nottingham, UK/Academic Neurology, Nottingham University Hospitals NHS Trust, Nottingham, UK – sequence: 4 givenname: Douglas David surname: Gunzler fullname: Gunzler, Douglas David organization: The MetroHealth System and Case Western Reserve University, Cleveland, OH, USA – sequence: 5 givenname: Stephen William surname: Gerry fullname: Gerry, Stephen William organization: Centre for Statistics in Medicine, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK – sequence: 6 givenname: Sarah Marie orcidid: 0000-0002-5093-0754 surname: Planchon fullname: Planchon, Sarah Marie organization: Mellen Center for Multiple Sclerosis, Cleveland Clinic, Cleveland, OH, USA – sequence: 7 givenname: Roshan orcidid: 0000-0001-8143-7893 surname: das Nair fullname: das Nair, Roshan organization: Mental Health and Clinical Neurosciences Academic Unit, School of Medicine, University of Nottingham, Nottingham, UK/Institute of Mental Health, Nottinghamshire Healthcare NHS Foundation Trust, Nottingham, UK – sequence: 8 givenname: Jeremy surname: Chataway fullname: Chataway, Jeremy organization: Queen Square Multiple Sclerosis Centre, Department of Neuroinflammation, UCL Queen Square Institute of Neurology, Faculty of Brain Sciences, University College London, London, UK/National Institute for Health Research, University College London Hospitals Biomedical Research Centre, London, UK/MRC CTU at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK – sequence: 9 givenname: Emma C orcidid: 0000-0002-3760-6634 surname: Tallantyre fullname: Tallantyre, Emma C organization: Helen Durham Neuro-Inflammatory Unit, University Hospital of Wales, Cardiff, UK/Division of Psychological Medicine and Clinical Neurosciences, Cardiff University, Cardiff, UK – sequence: 10 givenname: Daniel orcidid: 0000-0002-2838-9148 surname: Ontaneda fullname: Ontaneda, Daniel organization: Mellen Center for Multiple Sclerosis, Cleveland Clinic, Cleveland, OH, USA – sequence: 11 givenname: Nikos orcidid: 0000-0003-2871-0672 surname: Evangelou fullname: Evangelou, Nikos email: nikos.evangelou@nottingham.ac.uk organization: Mental Health and Clinical Neurosciences Academic Unit, School of Medicine, University of Nottingham, Nottingham, UK/Academic Neurology, Nottingham University Hospitals NHS Trust, Nottingham, UK |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/35735014$$D View this record in MEDLINE/PubMed |
BookMark | eNplkM1OwzAQhC1URH_gAbigvEDKrtepXYkLKr9SJS5wjjbOBlylaWWnB96eVIUTpxlpP41mZ6pG3a4Tpa4R5ojW3iIV2hSu0BoRwACeqQkaa3NYWhgNfrjnR2CspiltAMBaKi7UmIpBAc1E3T2Il66P3IYkdebb0AXPbdbHwG3KQpdtD20f9q1kybcSdymkLEoSjv7rUp03AyVXvzpTH0-P76uXfP32_Lq6X-feLBZ97mylCaqmcaT1ko3TjrU32ECtKybrDHuqahTCitlYaYjIESxRkBk8zdTNKXd_qLZSl_sYthy_y783BmB-AhJ_SrnZHWI39CkRyuNO5b-d6AcoBVkA |
CitedBy_id | crossref_primary_10_1007_s40290_024_00518_x crossref_primary_10_1002_bimj_202200370 |
ContentType | Book Review Journal Article |
Copyright | The Author(s), 2022 |
Copyright_xml | – notice: The Author(s), 2022 |
DBID | AFRWT CGR CUY CVF ECM EIF NPM |
DOI | 10.1177/13524585221100401 |
DatabaseName | Sage Journals GOLD Open Access 2024 Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) |
DatabaseTitleList | MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: AFRWT name: Sage Journals GOLD Open Access 2024 url: http://journals.sagepub.com/ sourceTypes: Publisher |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1477-0970 |
EndPage | 325 |
ExternalDocumentID | 35735014 10.1177_13524585221100401 |
Genre | Journal Article Review |
GroupedDBID | --- -MK -TM .2E .2F .2G .2J .2N 01A 0R~ 123 18M 1~K 29M 31R 31S 31U 31X 31Y 31Z 36B 39C 3V. 4.4 53G 54M 5VS 7X7 88E 8FI 8FJ 8R4 8R5 AABMB AABOD AACKU AACMV AACTG AADTT AADUE AAEWN AAGGD AAGMC AAJIQ AAJOX AAJPV AAKGS AAMGE AANSI AAPEO AAQDB AAQXH AARDL AARIX AATAA AATBZ AAUAS AAXOT AAYTG AAZBJ ABAFQ ABAWC ABAWP ABCCA ABDWY ABEIX ABFWQ ABHFT ABHKI ABHQH ABJIS ABJNI ABKRH ABLUO ABNCE ABPGX ABPNF ABQKF ABQXT ABRHV ABUWG ABVFX ABVVC ABYTW ACARO ACDSZ ACDXX ACFEJ ACFMA ACFYK ACGBL ACGFO ACGFS ACGZU ACJTF ACLFY ACLHI ACLZU ACNXM ACOFE ACOXC ACPRK ACROE ACSBE ACSIQ ACTQU ACUAV ACUIR ACXKE ACXMB ADBBV ADEIA ADMPF ADNBR ADRRZ ADTBJ ADUCT ADUKL ADZYD ADZZY AECGH AECVZ AEDTQ AEKYL AENEX AEPTA AEQLS AERKM AESZF AEUHG AEUIJ AEWDL AEWHI AEXFG AEXNY AFEET AFKBI AFKRA AFKRG AFMOU AFQAA AFRWT AFUIA AGKLV AGNHF AGWFA AHHFK AHMBA AIGRN AIOMO AJABX AJEFB AJMMQ AJSCY AJUZI AJXAJ ALIPV ALJHS ALMA_UNASSIGNED_HOLDINGS ALTZF AMCVQ ANDLU ARTOV ASPBG AUTPY AVWKF AYAKG AZFZN AZQEC B3H B8M B8O B8R B8Z B93 B94 BBRGL BDDNI BENPR BKIIM BKNYI BKSCU BPACV BPHCQ BSEHC BVXVI BWJAD BYIEH CAG CBRKF CCPQU CDWPY CFDXU COF CORYS CQQTX CS3 CUTAK DB0 DC- DC0 DD- DD0 DE- DF0 DO- DOPDO DU5 DV7 DV9 D~Y EBS EJD EMOBN ESX F5P FD6 FEDTE FHBDP FYUFA GROUPED_SAGE_PREMIER_JOURNAL_COLLECTION HF~ HMCUK HVGLF HZ~ J8X JCYGO K.F K.J K9- M0R M1P M4V N9A O9- P.B P2P PQQKQ PROAC PSQYO Q1R Q2X Q7K Q7L Q7R Q7U Q7X Q82 Q83 ROL S01 SCNPE SDB SFB SFC SFK SFN SFT SGA SGO SGP SGR SGV SGX SGZ SHG SNB SPJ SPQ SPV SQCSI STM UKHRP XJT ZONMY ZPPRI ZRKOI ZSSAH ACJER AFVCE AGWNL AJXGE ALKWR CGR CUY CVF ECM EIF H13 NPM |
ID | FETCH-LOGICAL-c466t-87b230bff83229a4828a2c41f0d2ba3784ac3bd1e31baa47ef33383091e1aa0c3 |
IEDL.DBID | AFRWT |
ISSN | 1352-4585 |
IngestDate | Wed Oct 16 00:39:29 EDT 2024 Tue Jul 16 20:52:49 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3 |
Keywords | clinical trial digital randomised controlled trial Decentralised remote multiple sclerosis |
Language | English |
License | This article is distributed under the terms of the Creative Commons Attribution 4.0 License (https://creativecommons.org/licenses/by/4.0/) which permits any use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c466t-87b230bff83229a4828a2c41f0d2ba3784ac3bd1e31baa47ef33383091e1aa0c3 |
ORCID | 0000-0002-8225-8747 0000-0001-8143-7893 0000-0002-3760-6634 0000-0003-2871-0672 0000-0002-5093-0754 0000-0001-9271-346X 0000-0002-2838-9148 |
OpenAccessLink | https://journals.sagepub.com/doi/full/10.1177/13524585221100401?utm_source=summon&utm_medium=discovery-provider |
PMID | 35735014 |
PageCount | 9 |
ParticipantIDs | pubmed_primary_35735014 sage_journals_10_1177_13524585221100401 |
PublicationCentury | 2000 |
PublicationDate | 2023-03-01 |
PublicationDateYYYYMMDD | 2023-03-01 |
PublicationDate_xml | – month: 03 year: 2023 text: 2023-03-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | London, England |
PublicationPlace_xml | – name: London, England – name: England |
PublicationTitle | Multiple Sclerosis Journal |
PublicationTitleAlternate | Mult Scler |
PublicationYear | 2023 |
Publisher | SAGE Publications |
Publisher_xml | – name: SAGE Publications |
References | Kim, Campbell, de Ávila 2019; 37 Raftery, Young, Stanton 2015; 19 Welch, Marshall, Qanungo 2016; 3 Bove, White, Giovannoni 2015; 2 Probstfield, Frye 2011; 306 Selker, Eichler, Stockbridge 2019; 105 Malmivaara 2019; 107 2019; 18 Ytterberg, Johansson, Andersson 2008; 255 Saslow, Li, Halper 2020; 22 Kasser, Goldstein, Wood 2017; 10 Gray 2006; 3 De Brouwer, Patel, Manrai 2021; 4 Fogel 2018; 11 Park, Mogg, Smith 2021; 9 De Angelis, Lavorgna, Carotenuto 2021; 10 Charvet, Dobbs, Shaw 2018; 24 Nordon, Karcher, Groenwold 2016; 19 Baird, Motl 2019; 33 Chataway, Porter, Riazi 2006; 5 Xue, Smietana, Poda 2020; 19 Rudd, Davis, Beidas 2020; 15 Robb, Hyland, Goodman 2019; 36 Treweek, Lockhart, Pitkethly 2013; 3 Wallstrom, Anderson, LaBaer 2013; 22 van Kempen, Hoogervorst, Wattjes 2020; 95 McKay, Tremlett, Zhu 2016; 23 Brueton, Tierney, Stenning 2014; 4 Huang, Bull, Johnston McKee 2018; 66 Skelton, Drey, Rutherford 2020; 143 Sommer, Zuccolin, Arnera 2018; 11 Coyle, Rogers, Copland 2022; 88 Walters, dos Anjos Henriques-Cadby, Bortolami 2017; 7 Tur, Moccia, Barkhof 2018; 14 Coran, Goldsack, Grandinetti 2019; 3 McDermott, Newman 2021; 325 Moore, Zhang, Anderson 2018; 178 Nicholas, Electricwala, Lee 2019; 19 Hartung 2017; 14 Midaglia, Mulero, Montalban 2019; 21 Breckenridge, Aronson, Blaschke 2017; 16 Carter, Humphreys, Snowdon 2015; 16 Hirsch, Martinez, Dorsey 2017; 39 Inan, Tenaerts, Prindiville 2020; 3 Lechner-Scott, Kappos, Hofman 2003; 9 Van Norman 2021; 6 das Nair, de Groot, Freeman 2019; 25 Jefferson, Fairhurst, Brealey 2018; 100 Brown, Weiss, Kolodny 2019; 19 Wald, McDaniel, Witzel 2020; 52 Chen, Qi 2020; 224 Aarestrup, Albeyatti, Armitage 2020; 12 Walden, Nahm, Barnett 2011; 164 Apostolaros, Babaian, Corneli 2020; 54 Galson, Austin, Khandekar 2021; 20 Monti, Grosso, Todoerti 2018; 57 Carlisle, Kimmelman, Ramsay 2015; 12 Lavorgna, Brigo, Moccia 2018; 24 Bradshaw, Farrow, Motl 2017; 7 |
References_xml | – volume: 224 start-page: 71 year: 2020 end-page: 77 article-title: Innovative highlights of clinical drug trial design publication-title: Transl Res contributor: fullname: Qi – volume: 4 year: 2014 article-title: Strategies to improve retention in randomised trials: A Cochrane systematic review and meta-analysis publication-title: BMJ Open contributor: fullname: Stenning – volume: 9 issue: 5 year: 2021 article-title: How COVID-19 has fundamentally changed clinical research in global health publication-title: Lancet Glob Health contributor: fullname: Smith – volume: 24 start-page: 1760 issue: 13 year: 2018 end-page: 1769 article-title: Remotely supervised transcranial direct current stimulation for the treatment of fatigue in multiple sclerosis: Results from a randomized, sham-controlled trial publication-title: Mult Scler contributor: fullname: Shaw – volume: 57 year: 2018 article-title: Randomized controlled trials and real-world data: Differences and similarities to untangle literature data publication-title: Rheumatology contributor: fullname: Todoerti – volume: 6 start-page: 384 issue: 4 year: 2021 end-page: 387 article-title: Decentralized clinical trials: The future of medical product development? publication-title: JACC Basic Transl Sci contributor: fullname: Van Norman – volume: 16 start-page: 149 issue: 3 year: 2017 end-page: 150 article-title: Poor medication adherence in clinical trials: Consequences and solutions publication-title: Nat Rev Drug Discov contributor: fullname: Blaschke – volume: 25 start-page: 1337 issue: 10 year: 2019 end-page: 1347 article-title: Beyond current research practice: Methodological considerations in MS rehabilitation research (is designing the perfect rehabilitation trial the Holy Grail or a Gordian knot?) publication-title: Mult Scler contributor: fullname: Freeman – volume: 19 start-page: 75 issue: 1 year: 2016 end-page: 81 article-title: The ‘efficacy-effectiveness gap’: Historical background and current conceptualization publication-title: Value Health contributor: fullname: Groenwold – volume: 14 start-page: 1018 issue: 4 year: 2017 end-page: 1026 article-title: Economics and cost-effectiveness of multiple sclerosis therapies in the USA publication-title: Neurotherapeutics contributor: fullname: Hartung – volume: 19 start-page: 258 year: 2019 article-title: Burden of relapsing-remitting multiple sclerosis on workers in the US: A cross-sectional analysis of survey data publication-title: BMC Neurol contributor: fullname: Lee – volume: 19 start-page: 287 year: 2019 article-title: Analysis of cardiac monitoring and safety data in patients initiating fingolimod treatment in the home or in clinic publication-title: BMC Neurol contributor: fullname: Kolodny – volume: 11 start-page: 156 year: 2018 end-page: 164 article-title: Factors associated with clinical trials that fail and opportunities for improving the likelihood of success: A review publication-title: Contemp Clin Trials Commun contributor: fullname: Fogel – volume: 100 start-page: 13 year: 2018 end-page: 21 article-title: Remote or on-site visits were feasible for the initial setup meetings with hospitals in a multicenter surgical trial: An embedded randomized trial publication-title: J Clin Epidemiol contributor: fullname: Brealey – volume: 88 start-page: 1031 year: 2022 end-page: 1042 article-title: Learning from remote decentralised clinical trial experiences: A qualitative analysis of interviews with trial personnel, patient representatives and other stakeholders publication-title: Br J Clin Pharmacol contributor: fullname: Copland – volume: 24 start-page: 1657 issue: 13 year: 2018 end-page: 1664 article-title: e-Health and multiple sclerosis: An update publication-title: Mult Scler contributor: fullname: Moccia – volume: 3 start-page: 145 issue: 3 year: 2019 end-page: 154 article-title: Advancing the use of mobile technologies in clinical trials: Recommendations from the clinical trials transformation initiative publication-title: Digit Biomark contributor: fullname: Grandinetti – volume: 37 start-page: 389 year: 2019 end-page: 406 article-title: Wearable biosensors for healthcare monitoring publication-title: Nat Biotechnol contributor: fullname: de Ávila – volume: 52 start-page: 686 issue: 3 year: 2020 end-page: 696 article-title: Low-cost and portable MRI publication-title: J Magn Reson Imaging contributor: fullname: Witzel – volume: 19 start-page: 1 issue: 11 year: 2015 end-page: 166 article-title: Clinical trial metadata: Defining and extracting metadata on the design, conduct, results and costs of 125 randomised clinical trials funded by the National Institute for Health Research Health Technology Assessment programme publication-title: Health Technol Assess contributor: fullname: Stanton – volume: 7 year: 2017 article-title: Recruitment and retention of participants in randomised controlled trials: A review of trials funded and published by the United Kingdom Health Technology Assessment Programme publication-title: BMJ Open contributor: fullname: Bortolami – volume: 3 start-page: 538 issue: 6 year: 2006 end-page: 542 article-title: Cost-effectiveness analyses alongside randomised clinical trials publication-title: Clin Trials contributor: fullname: Gray – volume: 3 issue: 2 year: 2013 article-title: Methods to improve recruitment to randomised controlled trials: Cochrane systematic review and meta-analysis publication-title: BMJ Open contributor: fullname: Pitkethly – volume: 20 start-page: 259 issue: 4 year: 2021 end-page: 260 article-title: The failure to fail smartly publication-title: Nat Rev Drug Discov contributor: fullname: Khandekar – volume: 5 start-page: 565 issue: 7 year: 2006 end-page: 571 article-title: Home versus outpatient administration of intravenous steroids for multiple-sclerosis relapses: A randomised controlled trial publication-title: Lancet Neurol contributor: fullname: Riazi – volume: 11 start-page: 120 year: 2018 end-page: 126 article-title: Building clinical trials around patients: Evaluation and comparison of decentralized and conventional site models in patients with low back pain publication-title: Contemp Clin Trials Commun contributor: fullname: Arnera – volume: 10 start-page: 2328 year: 2021 article-title: Digital technology in clinical trials for multiple sclerosis: Systematic review publication-title: J Clin Med contributor: fullname: Carotenuto – volume: 54 start-page: 779 issue: 4 year: 2020 end-page: 787 article-title: Legal, regulatory, and practical issues to consider when adopting decentralized clinical trials: Recommendations from the clinical trials transformation initiative publication-title: Ther Innov Regul Sci contributor: fullname: Corneli – volume: 325 start-page: 1935 year: 2021 end-page: 1936 article-title: Remote research and clinical trial integrity during and after the coronavirus pandemic publication-title: JAMA contributor: fullname: Newman – volume: 22 start-page: 747 issue: 5 year: 2013 end-page: 755 article-title: Biomarker discovery for heterogeneous diseases publication-title: Cancer Epidemiol Biomarkers Prev contributor: fullname: LaBaer – volume: 12 start-page: 18 year: 2020 article-title: Towards a European health research and innovation cloud (HRIC) publication-title: Genome Med contributor: fullname: Armitage – volume: 7 start-page: 354 issue: 4 year: 2017 end-page: 362 article-title: Wearable biosensors to monitor disability in multiple sclerosis publication-title: Neurol Clin Pract contributor: fullname: Motl – volume: 105 start-page: 857 issue: 4 year: 2019 end-page: 866 article-title: Efficacy and effectiveness too trials: Clinical trial designs to generate evidence on efficacy and on effectiveness in wide practice publication-title: Clin Pharmacol Ther contributor: fullname: Stockbridge – volume: 306 start-page: 1798 year: 2011 end-page: 1799 article-title: Strategies for recruitment and retention of participants in clinical trials publication-title: JAMA contributor: fullname: Frye – volume: 3 start-page: 74 year: 2016 end-page: 79 article-title: Teleconsent: A novel approach to obtain informed consent for research publication-title: Contemp Clin Trials Commun contributor: fullname: Qanungo – volume: 19 start-page: 662 issue: 10 year: 2020 end-page: 663 article-title: Clinical trial recovery from COVID-19 disruption publication-title: Nat Rev Drug Discov contributor: fullname: Poda – volume: 14 start-page: 75 issue: 2 year: 2018 end-page: 93 article-title: Assessing treatment outcomes in multiple sclerosis trials and in the clinical setting publication-title: Nat Rev Neurol contributor: fullname: Barkhof – volume: 18 start-page: 269 issue: 3 year: 2019 end-page: 285 article-title: Global, regional, and national burden of multiple sclerosis 1990–2016: A systematic analysis for the Global Burden of Disease Study 2016 publication-title: Lancet Neurol – volume: 36 start-page: 101258 year: 2019 article-title: Comparison of telemedicine versus in-person visits for persons with multiple sclerosis: A randomized crossover study of feasibility, cost, and satisfaction publication-title: Mult Scler Relat Disord contributor: fullname: Goodman – volume: 3 start-page: 101 year: 2020 article-title: Digitizing clinical trials publication-title: npj Digit Med contributor: fullname: Prindiville – volume: 178 start-page: 1451 year: 2018 end-page: 1457 article-title: Estimated costs of pivotal trials for novel therapeutic agents approved by the US Food and Drug Administration, 2015-2016 publication-title: JAMA Intern Med contributor: fullname: Anderson – volume: 39 start-page: 1064 issue: 5 year: 2017 end-page: 1076 article-title: Incorporating site-less clinical trials into drug development: A framework for action publication-title: Clin Ther contributor: fullname: Dorsey – volume: 12 start-page: 77 issue: 1 year: 2015 end-page: 83 article-title: Unsuccessful trial accrual and human subjects protections: An empirical analysis of recently closed trials publication-title: Clin Trials contributor: fullname: Ramsay – volume: 66 start-page: 74 year: 2018 end-page: 79 article-title: Clinical trials recruitment planning: A proposed framework from the clinical trials transformation initiative publication-title: Contemp Clin Trials contributor: fullname: Johnston McKee – volume: 15 start-page: 103 year: 2020 article-title: Integrating implementation science in clinical research to maximize public health impact: A call for the reporting and alignment of implementation strategy use with implementation outcomes in clinical research publication-title: Implement Sci contributor: fullname: Beidas – volume: 4 start-page: 102 year: 2021 article-title: Empowering clinical research in a decentralized world publication-title: npj Digit Med contributor: fullname: Manrai – volume: 21 year: 2019 article-title: Adherence and satisfaction of smartphone-and smartwatch-based remote active testing and passive monitoring in people with multiple sclerosis: Nonrandomized interventional feasibility study publication-title: J Med Internet Res contributor: fullname: Montalban – volume: 22 start-page: 226 issue: 5 year: 2020 end-page: 232 article-title: An international standardized magnetic resonance imaging protocol for diagnosis and follow-up of patients with multiple sclerosis: Advocacy, dissemination, and implementation strategies publication-title: Int J MS Care contributor: fullname: Halper – volume: 10 start-page: 207 issue: 2 year: 2017 end-page: 213 article-title: Symptom variability, affect and physical activity in ambulatory persons with multiple sclerosis: Understanding patterns and time-bound relationships publication-title: Disabil Health J contributor: fullname: Wood – volume: 33 start-page: 3 issue: 1 year: 2019 end-page: 14 article-title: Response heterogeneity with exercise training and physical activity interventions among persons with multiple sclerosis publication-title: Neurorehabil Neural Repair contributor: fullname: Motl – volume: 164 start-page: 82 year: 2011 end-page: 88 article-title: Economic analysis of centralized vs. decentralized electronic data capture in multi-center clinical studies publication-title: Stud Health Technol Inform contributor: fullname: Barnett – volume: 2 issue: 6 year: 2015 article-title: Evaluating more naturalistic outcome measures: A 1-year smartphone study in multiple sclerosis publication-title: Neurol Neuroimmunol Neuroinflamm contributor: fullname: Giovannoni – volume: 255 start-page: 967 issue: 7 year: 2008 end-page: 973 article-title: Variations in functioning and disability in multiple sclerosis publication-title: J Neurol contributor: fullname: Andersson – volume: 16 start-page: 468 year: 2015 article-title: Participant recruitment into a randomised controlled trial of exercise therapy for people with multiple sclerosis publication-title: Trials contributor: fullname: Snowdon – volume: 143 start-page: 104271 year: 2020 article-title: Electronic consenting for conducting research remotely: A review of current practice and key recommendations for using e-consenting publication-title: Int J Med Inform contributor: fullname: Rutherford – volume: 95 year: 2020 article-title: Personalized extended interval dosing of natalizumab in MS: A prospective multicenter trial publication-title: Neurology contributor: fullname: Wattjes – volume: 23 start-page: 1093 issue: 6 year: 2016 end-page: 1100 article-title: A population-based study comparing multiple sclerosis clinic users and non-users in British Columbia, Canada publication-title: Eur J Neurol contributor: fullname: Zhu – volume: 9 start-page: 154 year: 2003 end-page: 159 article-title: Can the Expanded Disability Status Scale be assessed by telephone? publication-title: Mult Scler contributor: fullname: Hofman – volume: 107 start-page: 36 year: 2019 end-page: 41 article-title: Generalizability of findings from randomized controlled trials is limited in the leading general medical journals publication-title: J Clin Epidemiol contributor: fullname: Malmivaara |
SSID | ssj0007735 |
Score | 2.4402604 |
SecondaryResourceType | review_article |
Snippet | Randomised controlled trials (RCTs) play an important role in multiple sclerosis (MS) research, ensuring that new interventions are safe and efficacious before... |
SourceID | pubmed sage |
SourceType | Index Database Publisher |
StartPage | 317 |
SubjectTerms | COVID-19 - epidemiology Humans Multiple Sclerosis Telemedicine |
Title | Decentralised clinical trials in multiple sclerosis research |
URI | https://journals.sagepub.com/doi/full/10.1177/13524585221100401 https://www.ncbi.nlm.nih.gov/pubmed/35735014 |
Volume | 29 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1LS8NAEB5qC6In39ZH2YPgKbb7aDYFQUQtRWgRabG3sLvZYA9NxaQH_707yUYKevAaApOdzby_mQG4smnUM4bh6Ms0DEQUJoF2VjZQlimaGKYkw27k8SQczcTzvD9vwKruhfEczG8QVuW-qFTWKN2Yje76ImOXOrdBOEeXsXLiWY_erYtlXKW7660a-ATr0-sllrYNAiK_grq9bQtaTlRl1ITW_fD1bfqjvKUsd3IigQAp-ELon0Q3jNYGCqw0TMM92MVmBVJl-PehYbMD2B77evkh3D5aj75c5DYhdRskKXd15GSRkRpQSHL3_ziLuciJn__zfgSz4dP0YRT4fQmBEWFYOMWmXUCh0xSldKCEC6YUM4KmvYRpxWUklOE6oZZTrZSQNuUYoDqPwVKleoYfQzNbZfYUiKU2VDp0zuPAilT2lTux5kJZF0wPuEjacFIdPf6ohmLEvC_LGmUbrpEXcX2RMfUDxX-x7-zfb57DDm55r6BfF9AsPtf20vkChe74--vA1uRl_A1c4a3d |
link.rule.ids | 314,783,787,795,21978,27865,27934,27937,44957,45345 |
linkProvider | SAGE Publications |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV07T8MwED6hVuIx8aY8PSAxBdWP2K3EgoCqQNsBtaJbZDtntUtApPx_7MStKsHAHkfx2b7vLv6-O4BrdJ22tSyUvnQyER2ZJ8ajbKKRaZpbphULauThSPYn4mWaTiOrMmhhogXL20Cr8l9UOevV6Q46cR8xCB_jMlYVOwvSraZIuUgb0Lzvvb2PV35Yqaq9ZhiQhBHxTvPPl6zhzxqhq8KY3i7sBN0BqX_W78EGFvuwOYxX3wdw94iRSDkvMSdLRSOp2m6UZF6QJTeQlH4rePCblySW8pkdwqT3NH7oJ7H1QWKFlAvvo4zPDYxz4cB1tfB5kWZWUNfOmdFcdYS23OQUOTVaC4WOh1zTgz9SrduWH0Gj-CjwBAhSlNpIHwd2UTiVaj9jw4VGnxd3uchbcFxPPfus61tkPFXVdWMLboItsuWaZDTWBv9lvtN_P3kFW_3xcJANnkevZ7AdmrfXjK5zaCy-vvHCQ_zCXMa1_AHRB5o0 |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1LSwMxEA7SQtGTb-szB8HT2ubRpAUvYl3qo0Wkxd6WPHEva3Hr_3eym0pBD96TsJls5pvJfDOD0KXz_a4xNJS-9CLhfWETDSibKEcVsYYqSUM28ngiRjP-OO_N44NbyIWJEiyvA60KvqhS1uF2L6zvxBhjh4DVwMHOpbQqeBbSt5ocLH1wvpq36evb9EcXS1m12AwTkjAjxjX_XGQNg9ZIXRXOpNtoK-Qe4PrBfgdtuGIXtcYx_L2HboYukinz0lm8ymrEVeuNEucFXvEDcQm_AwBgXuJYzud9H83S--ndKIntDxLDhViCntLgH2jvw6UbKA6-kaKGE9-1VCsm-1wZpi1xjGiluHSeBX8TDABHlOoadoAaxUfhjhB2xAmlBdiCA8e97CnYsWZcOfCNB4zbNjqst54t6hoXGevJKuTYRldBFtnqXDIS64P_Et_xv0deoNbLMM2eHyZPJ2gz9G-vSV2nqLH8_HJngPJLfR6P8hty55tN |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Decentralised+clinical+trials+in+multiple+sclerosis+research&rft.jtitle=Multiple+Sclerosis+Journal&rft.au=Garjani%2C+Afagh&rft.au=Liu%2C+Brandon+Jun-Yu&rft.au=Allen%2C+Christopher+Martin&rft.au=Gunzler%2C+Douglas+David&rft.date=2023-03-01&rft.pub=SAGE+Publications&rft.issn=1352-4585&rft.eissn=1477-0970&rft.volume=29&rft.issue=3&rft.spage=317&rft.epage=325&rft_id=info:doi/10.1177%2F13524585221100401&rft.externalDocID=10.1177_13524585221100401 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1352-4585&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1352-4585&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1352-4585&client=summon |